改变约旦的癌症照护:由当地专家指导的10年以患者为中心的综合策略
本文是一篇系列文章,由约旦肿瘤照护与医学教育专家团队提出约旦10年综合癌症控制策略,评估现状、差距与挑战,并推荐纠正措施。框架涵盖公众意识与教育、预防、筛查、公平获得优质照护、照护后监测、生存者支持与姑息治疗,以及人力培训、研究和支持服务,强调采用循证实践、创新干预和标准化肿瘤实践,并呼吁建立共识框架以评估和监测实施。
要点
- 提出约旦10年综合癌症控制策略,以患者为中心、追求全面普惠的癌症照护。
- 框架涵盖预防、筛查、公平获得优质照护、生存者支持与姑息治疗等环节。
- 强调循证实践、创新干预、标准化肿瘤实践,并采用Common Sense Oncology方法。
核心结论
- 该系列文章提出约旦10年综合癌症控制策略,旨在建立稳健、以患者为中心、有韧性的卫生保健系统,优先实现全面普惠的癌症照护。
研究设计与样本
- 本文为系列文章,由一组约旦肿瘤照护与医学教育领域的医学专家提出策略框架。
主要发现
- 文章评估了约旦癌症照护的现状、差距与挑战,并推荐纠正措施以应对这些问题。
关键数值与推荐
- 框架涵盖公众意识与教育、预防、筛查、公平获得优质照护、照护后监测、生存者支持与姑息治疗,以及人力培训、研究和支持服务。
- 强调采用循证实践、创新干预和与约旦相关的肿瘤学原则,包括标准化肿瘤实践。
- 呼吁建立基于共识的框架,以评估和监测实施,确保系统有效性和连续性,采用Common Sense Oncology方法。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this Series paper, we propose a comprehensive, 10-year cancer control strategy for Jordan, as outlined by a group of Jordanian medical experts in cancer care and medical education. The strategy is designed to create a robust, patient-centred, resilient health-care system in which comprehensive universal cancer care is prioritised. We include an assessment of the current state, gaps, and challenges for cancer care in Jordan, and recommend corrective actions to address them. The proposed framework discusses cancer care in Jordan, including public awareness and education, prevention, screening, equitable access to quality care, post-care monitoring, survivorship, and palliative care. In addition to workforce training, research, and supportive services, this framework emphasises the need to adopt evidence-based practices, innovative interventions, and adherence to oncological principles relevant to Jordan, including standardising oncology practices. This strategy calls for creating a consensus-based framework to evaluate and monitor implementation, ensuring the effectiveness and continuity of the system in a cost-effective and applicable manner, with use of a Common Sense Oncology approach.
引用
- Abdel-Razeq H, Rayyan Y, Al-Rabi K, et al. Transforming cancer care in Jordan: a 10-year comprehensive patient-centred strategy guided by local experts. Lancet Oncol. 2025. PMID: 40516555. doi:10.1016/S1470-2045(25)00129-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。